[ad_1] Mumbai: The White House’s reported decision to shelve plans for tariff on generic drug imports will be a relief to Indian pharmaceutical companies, which account for nearly half of all generic prescriptions in the United States. Industry experts said even as there was a lot of speculation about tariff imposition across the pharma community,…
[ad_1] The Union Commerce ministry has told a parliamentary panel that fresh US tariffs on pharmaceutical imports are unlikely to significantly hit India, as the country primarily exports generic drugs rather than patented ones that are more affected by the decision, The Times of India reported on September 30. At a meeting of the Public…
[ad_1] India targets new markets for pharma export growth amid US tariffs concerns We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok [ad_2] Source link
[ad_1] India plans to increase pharmaceutical exports to Russia, the Netherlands and Brazil, according to two industry sources aware of the matter, aiming to expand its presence beyond the United States, its largest market, amid tariff-related concerns. India’s pharmaceutical industry is currently exempt from U.S. President Donald Trump‘s tariffs of up to 50% but the…